Harbor Diversified HRBR · USD

Its shares trade under the ticker HRBR. It has been listed since 8 September 1997. In the fiscal year to 31 December 2024, it reported revenue of $199.2m and a net loss of $16.0m. At that date it held total assets of $236.3m and shareholders' equity of $176.6m.

Harbor Diversified, Inc. is a development stage pharmaceutical company, which engages in the discovery, development, and commercialization of products for the treatment of diseases related to aging. The company is headquartered in Appleton, Wisconsin. The company is engaged in the discovery and development of products for the treatment of diseases that typically onset with age. The company is primarily focused on the development of a series of hormone-related sterols that are derived from the human adrenal metabolome. The firm is development-stage company with two product candidates: Apoptone (HE3235) in patients with late-stage prostate cancer, and Triolex (HE3286) in obese type-2 diabetes mellitus patients. The firm focuses on the development of synthetic sterol derivatives derived from the human 19-carbon steroid scaffold of the mammalian sterol metabolome. The company has conducted clinical trials with its drug development candidates, which include Apoptone (HE3235); Triolex (HE3286); Neumune (HE2100), for the treatment of sepsis, and HE2000, for the prevention of opportunistic infections in immune-suppressed patients.

Figures and description from our data supplier, not checked against the company's own report.

• Ms. Christine DeisterChief Executive Officer, Secretary$235,000
• Mr. Robert BinnsChief Executive Officer, President of Air Wisconsin Airlines LLC$1.1m
• Mr. Gregg GarveySenior Vice President, Chief Financial Officer, Principal Accounting Officer, Treasurer of Air Wisconsin Airlines LLC
• Mr. Richard BartlettDirector$80,000
• Mr. Nolan BedermanIndependent Director$106,000
• Mr. Kevin DegenIndependent Director$106,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.